חזרה לתוצאות החיפוש

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Growth Hormone Deficiency (GHD)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Lumos Pharma Investigational Site, Birmingham, Alabama, United States

  • Lumos Pharma Investigational Site, Madera, California, United States

  • Lumos Pharma Investigational Site, Orange, California, United States

  • Lumos Pharma Investigational Site, Sacramento, California, United States

  • Lumos Pharma Investigational Site, San Diego, California, United States

  • Lumos Pharma Investigational Site, Centennial, Colorado, United States

  • Lumos Pharma Investigational Site, Greenwood Village, Colorado, United States

  • Lumos Pharma Investigational Site, Washington D.C., District of Columbia, United States

  • Lumos Pharma Investigational Site, Hollywood, Florida, United States

  • Lumos Pharma Investigational Site, Miami, Florida, United States

  • Lumos Pharma Investigational Site, Orlando, Florida, United States

  • Lumos Pharma Investigational Site, Tallahassee, Florida, United States

  • Lumos Pharma Investigational Site, Indianapolis, Indiana, United States

  • Lumos Pharma Investigational Site, Iowa City, Iowa, United States

  • Lumos Pharma Investigational Site, New Orleans, Louisiana, United States

  • Lumos Pharma Investigational Site, Minneapolis, Minnesota, United States

  • Lumos Pharma Investigational Site, Kansas City, Missouri, United States

  • Lumos Pharma Investigational Site, Las Vegas, Nevada, United States

  • Lumos Pharma Investigational Site, New Brunswick, New Jersey, United States

  • Lumos Pharma Investigational Site, Staten Island, New York, United States

  • Lumos Pharma Investigational Site, Oklahoma City, Oklahoma, United States

  • Lumos Pharma Investigational Site, Columbia, South Carolina, United States

  • Lumos Pharma Investigational Site, Amarillo, Texas, United States

  • Lumos Pharma Investigational Site, Corpus Christi, Texas, United States

  • Lumos Pharma Investigational Site, Fort Worth, Texas, United States

  • Lumos Pharma Investigational Site, San Antonio, Texas, United States

  • Lumos Pharma Investigational Site, Charlottesville, Virginia, United States

  • Lumos Pharma Investigational Site, Seattle, Washington, United States

  • Lumos Pharma Investigational Site, South Brisbane, Queensland, Australia

  • Lumos Pharma Investigational Site, Clayton, Victoria, Australia

  • Lumos Pharma Investigational Site, Parkville, Victoria, Australia

  • Lumos Pharma Investigational Site, Auckland, New Zealand

  • Lumos Pharma Investigational Site, Wellington, New Zealand

  • Lumos Pharma Investigational Site, Bangkok Noi, Bangkok, Thailand

  • Lumos Pharma Investigational Site, Pathumwan, Bangkok, Thailand

  • Lumos Pharma Investigational Site, Muang, Changwat Khon Kaen, Thailand

  • Lumos Pharma Investigational Site, Hat Yai, Changwat Songkhla, Thailand

  • Lumos Pharma Investigational Site, Muang, Chiang Mai, Thailand

  • Lumos Pharma Investigational Site, Liverpool, England, United Kingdom

  • Lumos Pharma Investigational Site, London, England, United Kingdom

  • Lumos Pharma Investigational Site, London, England, United Kingdom

  • Lumos Pharma Investigational Site, Sheffield, England, United Kingdom

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)